EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Role of CD14 in human disease

Daniel Sharygin, Leonidas G Koniaris, Clark Wells, Teresa A Zimmers, Tewfik Hamidi iD

Immunology · 2023-07 · 169 (3) · 260-270

DOI: 10.1111/imm.13634 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology, online erschienen am 27.03.2023. Verfasst von Daniel Sharygin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Endothelial Cells, Toll-Like Receptor 4. Die Arbeit wurde bisher 139-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cell surface antigen CD14 is primarily understood to act as a co‐receptor for toll‐like receptors (TLRs) to activate innate immunity responses to pathogens and tissue injury in macrophages and monocytes. However, roles for CD14 are increasingly being uncovered in disease responses in epithelial and endothelial cells. Consistent with these broader functions, CD14 expression is altered in a variety of non‐immune cell types in response to a several of disease states. Moreover, soluble CD14 activated by factors from both pathogens and tissue damage may initiate signalling in a variety of non‐immune cells. This review examined the current understanding CD14 in innate immunity as well as its potential functions in nonimmune cells and associated human diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsToll-Like Receptor 4HumansLipopolysaccharidesToll-Like ReceptorsMacrophagesLipopolysaccharide Receptors

Stichwörter der Autor:innen

CD14LPShuman diseaseimmunityinflammationmetabolismorgan injury

Substanzen

Toll-Like Receptor 4LipopolysaccharidesToll-Like ReceptorsLipopolysaccharide Receptors

Autor:innen und Institutionen

  • Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Indiana University Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.
  • Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

ORCID-Profile: Tewfik Hamidi

Förderung

  • BLRD VA
  • NIGMS NIH HHS
  • National Institutes of Health
  • National Institute of General Medical Sciences

Zitieren

APA

Sharygin, D., Koniaris, L. G., Wells, C., Zimmers, T. A., & Hamidi, T. (2023). Role of CD14 in human disease. Immunology, 169(3), 260-270. https://doi.org/10.1111/imm.13634

Vancouver

Sharygin D, Koniaris LG, Wells C, Zimmers TA, Hamidi T. Role of CD14 in human disease. Immunology. 2023;169(3):260-270. doi:10.1111/imm.13634

BibTeX
@article{Sharygin2023,
  author = {Sharygin, Daniel and Koniaris, Leonidas G and Wells, Clark and Zimmers, Teresa A and Hamidi, Tewfik},
  title = {Role of CD14 in human disease},
  journal = {Immunology},
  year = {2023},
  volume = {169},
  number = {3},
  pages = {260--270},
  doi = {10.1111/imm.13634}
}
Kostenlos starten →